Saama’s Chief Technology Officer & Chief Product Officer Lisa Moneymaker Named to ACRO Board of Directors

Campbell, Calif. – March 29, 2023 – Saama, a provider of AI- and ML -based data analytics solutions that accelerate clinical trial processes, has announced that its Chief Technology Officer (CTO) and Chief Product Officer (CPO) Lisa Moneymaker has been appointed to the Association of Clinical Research Organizations’ (ACRO) Board of Directors. 

Moneymaker joins a distinguished bench of drug development, technology, and business executives committed to improving the quality and safety of the clinical research process to protect patients and deliver high-quality treatments and therapies.

ACRO advocates as the collective voice of innovative clinical research and technology organizations to regulators and policymakers, educating stakeholders, and shaping policies that foster efficient, effective, and safe conduct of clinical research.

“As developments in biomedical research rapidly accelerate the clinical trial process, the need for effective, safe, and optimized clinical trials is of utmost importance,” said Moneymaker. “ACRO’s world-class expertise, advocacy, and commitment to advancing life-saving treatments is leading the industry to new breakthroughs that improve and save lives, and I look forward to the collaborative work of advancing this progress.” 

Moneymaker joined Saama in 2022 with more than 20 years of experience in the pharma, biotech, and medical device industries with a track record of delivering complex systems in support of excellence in clinical trial execution. As CTO and CPO of Saama, she’s driving the company’s technology vision and product strategy, bringing to market life science solutions that deliver breakthrough intelligence and advance clinical commercial operations. 

“Moneymaker will be a valuable asset to ACRO’s Board of Directors and its greater mission to advance clinical research, strengthen public understanding and confidence, and promote a more efficient clinical trial process,” said Douglas Peddicord, Ph.D., Executive Director, ACRO. “We are pleased to welcome her to our Board of world-leading executives and eager to collaborate in pursuit of life-saving clinical advancements.”  

About Saama

Saama develops life science solutions that create efficiency and accelerate the delivery of therapies to patients. With innovative AI/ML technologies, Saama drives breakthrough intelligence into clinical and commercial operations. Saama’s Life Science Analytics Cloud (LSAC) powered the clinical trial that led to the world’s first COVID-19 vaccine. Headquartered in Campbell, CA, with employees around the globe, Saama is committed to helping customers save and improve lives. Discover more at

About ACRO

The Association of Clinical Research Organizations (ACRO) represents clinical research and technology companies that provide a variety of specialized services that support the development of new pharmaceuticals, biologics, and medical devices. Organized in late 2001, ACRO celebrated its 20th anniversary in March of 2022.

Media Contact

Denise DiMeglio

Gregory FCA

[email protected]